Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy

Completed · Phase 3

Conditions studied: Ovarian Cancer, Quality of Life

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Chemoprotective drugs such as amifostine may protect normal cells from the side effects of chemotherapy. PURPOSE: Randomized phase III trial to study the effectiveness of amifostine in treating patients who have ovarian epithelial cancer and who are receiving chemotherapy.

Key facts

Study ID

NCT00004166

Run by

Northwestern University

Starts

1999-10-01

Expected to finish

2003-01-01

Last updated by the study team

2012-06-06

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Robert H. Lurie Comprehensive Cancer Center, Northwestern University — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.